EKF Diagnostics Holdings plc
EKDHF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$146.53M
Close$
$0.67
102.9% upside
Current Fair Value
102.9% upsideUndervalued by 102.9% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $146.53 Million |
|---|---|
| Enterprise Value | $132.03 Million |
| Earnings per Share | $0 |
| Beta | 0.5 |
| Outstanding Shares | 431,009,566 |
Return
| Return on Equity | 12.25% |
|---|---|
| Return on Assets | 10.47% |
| Return on Invested Capital | 18.20% |
Valuation & Multiples
| P/E Ratio | 44.83 |
|---|---|
| PEG | 231.77 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 1.3 |
| Enterprise Value to EBIT | 9.6 |
| Enterprise Value to Net Income | 15 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Last Earnings Call
Report Date
September 15, 2026
EPS Estimate
$0.01
Consensus analyst estimateRevenue Estimate
$33.14 M
Consensus analyst estimateNext Earnings Call
Expected Date
March 30, 2027
EPS Estimate
$0.01
Consensus analyst estimateRevenue Estimate
$39.34 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About EKF Diagnostics Holdings plc
301 employees
CEO: Gavin Joseph Jones
EKF Diagnostics Holdings plc, a company founded in Cardiff, United Kingdom in 1990, specializes in the global design, development, manufacture, and sale of diagnostic instruments, reagents, and supporting products. Operating across Europ...